MA49959A - Formulation liposomale pour lubrification d'articulation - Google Patents

Formulation liposomale pour lubrification d'articulation

Info

Publication number
MA49959A
MA49959A MA049959A MA49959A MA49959A MA 49959 A MA49959 A MA 49959A MA 049959 A MA049959 A MA 049959A MA 49959 A MA49959 A MA 49959A MA 49959 A MA49959 A MA 49959A
Authority
MA
Morocco
Prior art keywords
liposomal formulation
joint lubrication
lubrication
joint
liposomal
Prior art date
Application number
MA049959A
Other languages
English (en)
Other versions
MA49959B1 (fr
Inventor
Maty Ayal-Hershkovitz
Yechezkel Barenholz
Yaniv Dolev
Gadi Sarfati
Keren Turjeman
Original Assignee
Moebius Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moebius Medical Ltd filed Critical Moebius Medical Ltd
Publication of MA49959A publication Critical patent/MA49959A/fr
Publication of MA49959B1 publication Critical patent/MA49959B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/10Materials for lubricating medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA49959A 2017-08-22 2018-08-21 Formulation liposomale pour lubrification d'articulation MA49959B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762548429P 2017-08-22 2017-08-22
PCT/IL2018/050923 WO2019038763A1 (fr) 2017-08-22 2018-08-21 Formulation liposomale pour lubrification d'articulation

Publications (2)

Publication Number Publication Date
MA49959A true MA49959A (fr) 2020-07-01
MA49959B1 MA49959B1 (fr) 2023-07-31

Family

ID=65439381

Family Applications (1)

Application Number Title Priority Date Filing Date
MA49959A MA49959B1 (fr) 2017-08-22 2018-08-21 Formulation liposomale pour lubrification d'articulation

Country Status (25)

Country Link
US (3) US11123293B2 (fr)
EP (2) EP3672653B1 (fr)
JP (2) JP7082336B2 (fr)
KR (2) KR102607729B1 (fr)
CN (2) CN111065423B (fr)
AU (3) AU2018319594B2 (fr)
BR (1) BR112020003767B1 (fr)
CA (2) CA3073368C (fr)
DK (1) DK3672653T3 (fr)
EA (1) EA202090476A1 (fr)
ES (1) ES2948715T3 (fr)
FI (1) FI3672653T3 (fr)
HR (1) HRP20230566T1 (fr)
HU (1) HUE062030T2 (fr)
IL (3) IL301801B2 (fr)
LT (1) LT3672653T (fr)
MA (1) MA49959B1 (fr)
MX (2) MX2020002041A (fr)
MY (1) MY197149A (fr)
PH (1) PH12020500331A1 (fr)
PL (1) PL3672653T3 (fr)
PT (1) PT3672653T (fr)
SG (1) SG11202000773QA (fr)
SI (1) SI3672653T1 (fr)
WO (1) WO2019038763A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI782181B (zh) * 2019-02-11 2022-11-01 以色列商莫比斯醫療有限公司 用於關節潤滑的脂質體調配物
JP2021013788A (ja) * 2020-11-10 2021-02-12 株式会社三洋物産 遊技機
AU2022425700A1 (en) * 2022-01-02 2024-07-18 Moebius Medical Ltd. Determination of the trapped volume of a liposome
EP4522178A1 (fr) 2023-01-19 2025-03-19 Moebius Medical Ltd. Composition liposomale à action prolongée pour le traitement de la douleur dans des troubles articulaires
KR20250018222A (ko) * 2023-07-26 2025-02-05 차의과학대학교 산학협력단 미토콘드리아가 캡슐화된 세포막 융합유도 리포좀을 포함하는 골관절염 치료를 위한 약학 조성물
IL314549A (en) * 2024-07-25 2026-02-01 Moebius Medical Ltd Liposomal conjugates and their uses

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
EP0319638A1 (fr) * 1987-12-08 1989-06-14 Estee Lauder Inc. Compositions cosmétiques et pharmaceutiques contenant des liposomes et procédés pour l'utilisation de telles compositions
US5941909A (en) * 1995-02-14 1999-08-24 Mentor Corporation Filling material for soft tissue implant prostheses and implants made therewith
AUPN723395A0 (en) 1995-12-19 1996-01-18 Macnaught Medical Pty Limited Lubrication methods
US6379648B1 (en) * 1999-02-01 2002-04-30 The Curators Of The University Of Missouri Biodegradable glass compositions and methods for radiation therapy
US6800298B1 (en) 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
JP2004521112A (ja) * 2001-01-24 2004-07-15 メステックス アクチエンゲゼルシャフト 関節痛治療薬を製造することへの神経毒性物質の使用
US6509027B2 (en) * 2001-02-12 2003-01-21 Supergen, Inc. Injectable pharmaceutical composition comprising coated particles of camptothecin
ATE424111T1 (de) 2001-03-29 2009-03-15 Scripps Research Inst Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
CA2451248A1 (fr) 2001-06-25 2003-01-03 Depuy International Limited Composition comprenant des glycosaminoglycanes et des inhibiteurs d'hyaluronidase destinee au traitement d'articulations arthritiques
IL159334A0 (en) * 2001-06-25 2004-06-01 Yissum Res Dev Co A method for preparation of vesicles loaded with biological material and different uses thereof
CA2451245A1 (fr) 2001-06-25 2003-01-03 Depuy International Limited Encapsulation liposomale de glycosaminoglycanes pour le traitement d'articulations arthrosees
DE10255106A1 (de) 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide
US7205006B2 (en) 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
EP1750671B1 (fr) 2004-06-03 2008-10-15 Bracco Research S.A. Assemblage liposomale pour son utilisation therapeutique et/ou diagnostique
US20050287180A1 (en) 2004-06-15 2005-12-29 Chen Andrew X Phospholipid compositions and methods for their preparation and use
US20070071840A1 (en) 2005-09-27 2007-03-29 Sridevi Dhanaraj Method for treatment of cartilage disorders with centella extract
ITPD20060202A1 (it) 2006-05-22 2007-11-23 Univ Degli Studi Trieste Miscele polimeriche di polisaccaridi anionici e cationici e loro impiego
JP5072275B2 (ja) * 2006-07-03 2012-11-14 テルモ株式会社 閉鎖小胞の分離方法、製剤の製造方法および評価方法
US20080027554A1 (en) * 2006-07-31 2008-01-31 Talmadge Karen D Kit and methods of treatment of an intervertebral disc
ES2599630T3 (es) 2006-09-28 2017-02-02 Hadasit Medical Research Services & Development Limited Uso de glicerofosfolípidos para lubricación de las articulaciones
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
JP2011512409A (ja) 2008-02-20 2011-04-21 イーエルシー マネージメント エルエルシー 皮膚を美白するための局所組成物及び方法
BR112012032153A2 (pt) 2010-06-17 2017-08-08 Yeda Res And Development Company Ltd método para a lubrificação de uma ou mais superfícies não biológicas, método para a lubrificação de uma ou mais superfícies de um tecido biológico em um indivíduo mamífero, uso de lipossomas na fase em gel e lipossoma misto
IL206739A (en) * 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
US20140038917A1 (en) 2011-04-19 2014-02-06 Anteis S.A. Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
GB201206486D0 (en) 2012-04-12 2012-05-30 Sequessome Technology Holdings Ltd Vesicular formulations and uses thereof
RU2677658C2 (ru) * 2012-07-05 2019-01-18 Тайвэн Липосом Ко, Лтд. Способы лечения артрита
CN104688721A (zh) 2014-10-11 2015-06-10 黄萍 一种含紫杉醇脂质体的抗类风湿性关节炎药物凝胶剂及其制备方法

Also Published As

Publication number Publication date
AU2023203309B2 (en) 2024-10-10
US20250114304A1 (en) 2025-04-10
HUE062030T2 (hu) 2023-09-28
MX2020002041A (es) 2020-08-13
IL312816B1 (en) 2026-02-01
CA3073368A1 (fr) 2019-02-28
PL3672653T3 (pl) 2023-08-14
IL272630A (en) 2020-03-31
EP3672653A1 (fr) 2020-07-01
EP3672653B1 (fr) 2023-03-29
HRP20230566T1 (hr) 2023-08-18
FI3672653T3 (fi) 2023-06-07
CN111065423B (zh) 2022-04-12
SI3672653T1 (sl) 2023-08-31
PT3672653T (pt) 2023-06-29
MX2023009082A (es) 2023-08-08
CA3073368C (fr) 2024-01-02
NZ761298A (en) 2024-03-22
US12214077B2 (en) 2025-02-04
JP7082336B2 (ja) 2022-06-08
IL301801B2 (en) 2024-10-01
MY197149A (en) 2023-05-26
KR20200044006A (ko) 2020-04-28
CA3219776A1 (fr) 2019-02-28
BR112020003767B1 (pt) 2023-10-10
EP4223284A1 (fr) 2023-08-09
SG11202000773QA (en) 2020-03-30
CN114601799B (zh) 2023-09-26
EA202090476A1 (ru) 2020-06-29
ES2948715T3 (es) 2023-09-18
US11123293B2 (en) 2021-09-21
AU2023203309A1 (en) 2023-06-22
WO2019038763A1 (fr) 2019-02-28
US20210369613A1 (en) 2021-12-02
JP7383759B2 (ja) 2023-11-20
JP2020531538A (ja) 2020-11-05
EP3672653A4 (fr) 2021-01-13
PH12020500331A1 (en) 2020-10-05
IL301801B1 (en) 2024-06-01
LT3672653T (lt) 2023-07-10
AU2025200077A1 (en) 2025-01-23
MA49959B1 (fr) 2023-07-31
US20200170948A1 (en) 2020-06-04
IL272630B2 (en) 2023-09-01
CN114601799A (zh) 2022-06-10
IL312816A (en) 2024-07-01
DK3672653T3 (da) 2023-06-12
JP2022110090A (ja) 2022-07-28
AU2018319594B2 (en) 2023-06-15
BR112020003767A2 (pt) 2020-09-01
AU2025200077B2 (en) 2026-01-08
KR20230166148A (ko) 2023-12-06
AU2018319594A1 (en) 2020-02-20
KR102607729B1 (ko) 2023-11-29
KR102808544B1 (ko) 2025-05-19
IL301801A (en) 2023-05-01
CN111065423A (zh) 2020-04-24
IL272630B1 (en) 2023-05-01

Similar Documents

Publication Publication Date Title
EP3672653A4 (fr) Formulation liposomale pour lubrification d'articulation
EP3479554A4 (fr) Mécanismes d'articulation motorisés
EP3425130C0 (fr) Élément d'usure pour équipement de terrassement
EP3446194A4 (fr) Raccourcis d'application pour carplay
EP3632394A4 (fr) Accessoire pour exercice de rééducation d'articulation
EP3302243A4 (fr) Technologies portables pour évaluation de santé d'articulation
EP3672650A4 (fr) Hydrogel pour l'ingénierie tissulaire et la bio-impression
EP3530828A4 (fr) Raccord d'articulation
EP3612173A4 (fr) Formulations pour la pulvérisation d'épinéphrine
EP3698760A4 (fr) Prothèse d'articulation d'épaule
EP3600272A4 (fr) Agents permettant d'augmenter la sécrétion des glandes lipidique de meibomius
EP3773410A4 (fr) Hydratant pour les yeux
EP3285698C0 (fr) Joint pour une orthèse d'articulation
EP3305291A4 (fr) Utilisation de dérivé de benzimidazole pour l'acidité nocturne
EP3529423C0 (fr) Connecteur amélioré pour une utilisation dans la formation de joints
EP3851506A4 (fr) Composition de graisse pour joint homocinétique
EP2953581A4 (fr) Dispositifs implantables pour défauts d'os ou d'articulation
EP3666861A4 (fr) Composition d'huile pour réfrigérateur
EP3445991A4 (fr) Agencement d'accouplement pour une boîte de vitesses
EP3421578A4 (fr) Composition d'huile lubrifiante
EP3371381A4 (fr) Agencement dans un joint articulé d'engin de chantier
EP3409750A4 (fr) Composition d'huile lubrifiante
EP3486509A4 (fr) Structure de soutien d'arbre pour corps pivotant
EP3559539A4 (fr) Organe d'accouplement graisseur
EP3727353A4 (fr) Formulations de tensioactifs pour l'inhalation